跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
drug delivery system
首页
药物
drug delivery system
drug delivery system
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ORAL DRUG DELIVERY SYSTEM COMPRISING HIGH VISCOSITY LIQUID CARRIER MATERIALS
EP 2959893 A1
申请人: DURECT CORP
优先权: 2002
CN
EP
US
24 件公开
NANOCELL DRUG DELIVERY SYSTEM
EP 1722762 A2
申请人: MASSACHUSETTS INST TECHNOLOGY
优先权: 2004
CN
EP
US
WO
8 件公开
US 2007053845 A1
申请人: SENGUPTA SHILADITYA
优先权: 2006
US
WO
5 件公开
Drug-delivery systems
US 8313778 B2
申请人: SEILER MATTHIAS
优先权: 2005
CN
EP
US
WO
8 件公开
AQUEOUS DRUG DELIVERY SYSTEM COMPRISING OFF-FLAVOR MASKING AGENT
EP 2616046 B1
申请人: BEV RX INC
优先权: 2010
CN
EP
US
WO
8 件公开
DRUG DELIVERY SYSTEM
US 2020330390 A1
申请人: LAXXON MEDICAL AG
优先权: 2017
CN
EP
US
WO
7 件公开
US 8333983 B2
申请人: GROENEWEGEN RUDOLF JOHANNES JOSEPH
优先权: 2004
CN
US
7 件公开
US 8486440 B2
申请人: WHITMORE ALAN
优先权: 2006
EP
US
WO
6 件公开
US 2008188571 A1
申请人: O'HARE DERMOT MICHAEL
优先权: 2000
US
WO
6 件公开
US 20250170055 A1
申请人: SEVER PHARMA SOLUTIONS
优先权: 2022
CN
EP
US
WO
5 件公开
US 9763884 B2
申请人: BLOEMERS JOHANNES MARTINUS MARIA
优先权: 2011
US
5 件公开
US 2005180997 A1
申请人: BENITA SIMON
优先权: 2004
CN
EP
US
WO
4 件公开
EP 3612231 C0
申请人: LIPOGEMS INT S P A
优先权: 2017
EP
US
WO
4 件公开
US 2014271872 A1
申请人: PATHEON INC
优先权: 2014
US
4 件公开
US 7862543 B2
申请人: GLIDE PHARMACEUTICAL TECHNOLOGIES LTD
优先权: 2002
CN
US
3 件公开
US 7059348 B2
申请人: FLUIDIGM CORP
优先权: 2003
US
3 件公开
US 8741329 B2
申请人: DE GRAAFF WOUTER
优先权: 2007
US
3 件公开
CN 1549703 A
申请人: SCHERING OY
优先权: 2001
CN
US
2 件公开
US 2007154516 A1
申请人: DRUGTECH CORP
优先权: 2006
CN
US
2 件公开
US 2012282340 A1
申请人: TEREBESI ILDIKO
优先权: 2008
CN
US
2 件公开
US 20250281617 A1
申请人: UNIV BIRMINGHAM
优先权: 2019
CN
US
2 件公开
US 2003039679 A1
申请人: DUIRS GRAHAM FRANCOIS
优先权: 1998
US
2 件公开
US 8772248 B2
申请人: BAILEY PATRICK DAWSON
优先权: 2004
US
2 件公开
US 8529929 B2
申请人: AOKI HIROKI
优先权: 2007
US
2 件公开
US 8734787 B2
申请人: MAGNANI MAURO
优先权: 2009
US
2 件公开
US 10500381 B2
申请人: BAYER OY
优先权: 2012
US
2 件公开
US 2015157561 A1
申请人: MERCK SHARP & DOHME
优先权: 2014
US
2 件公开
US 12685747 B2
申请人: UNIV IMAM ABDULRAHMAN BIN FAISAL
优先权: 2024
US
2 件公开
US 2006228408 A1
申请人: CHARMAN WILLIAM
优先权: 2003
US
US 8999356 B1
申请人: RAMIREZ JOSE E
优先权: 2005
US
CN 101366693 A
申请人: CONFLUENT SUGICAL INC
优先权: 2007
CN
US 2010196466 A1
申请人: CAPRICORN PHARMA INC
优先权: 2010
US
US 2011153027 A1
申请人: VYSERA BIOMEDICAL LTD
优先权: 2010
US
US 2013022675 A1
申请人: CAPRICORN PHARMA INC
优先权: 2012
US
CN 106103474 A
申请人: UCL BUSINESS PLC
优先权: 2014
CN
US 10888551 B2
申请人: INDIAN INST TECHNOLOGY BOMBAY
优先权: 2016
US
US 12144896 B2
申请人: INST NAT SANTE RECH MED
优先权: 2018
US
EP 4208233 B1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2020
EP
A GASTRORETENTIVE DRUG DELIVERY SYSTEM
US 2024065976 A1
申请人: DUPONT NUTRITION USA INC
优先权: 2021
CN
EP
US
WO
5 件公开
Enteric-coated proliposomal formulations for poorly water soluble drugs
US 6759058 B1
申请人: WESTERN CT FOR DRUG DEV COLLEG
优先权: 2001
CN
US
5 件公开
Contact drug delivery system
US 8349351 B2
申请人: UNIV AUBURN
优先权: 2006
US
5 件公开
Biodegradable drug delivery system
US 8231892 B2
申请人: LYONS ROBERT T
优先权: 2007
US
5 件公开
TRANSDERMAL DRUG DELIVERY PATCH, DRUG DELIVERY SYSTEM AND DRUG DELIVERY METHOD
EP 3989950 A4
申请人: PASSPORT TECH INC
优先权: 2019
EP
US
WO
4 件公开
第 1 / 5 页
上一页
下一页
药物
反馈